These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1384096)

  • 1. Immunopharmacology of new xenobiotic immunosuppressive molecules.
    Morris RE
    Semin Nephrol; 1992 Jul; 12(4):304-14. PubMed ID: 1384096
    [No Abstract]   [Full Text] [Related]  

  • 2. [New immunosuppressive drugs in transplantation].
    Surdacka E; Sułowicz W; Surdacki A
    Przegl Lek; 1994; 51(8):347-54. PubMed ID: 7532870
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
    Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
    Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
    [No Abstract]   [Full Text] [Related]  

  • 7. The spectrum of action of new immunosuppressive drugs.
    Thomson AW
    Clin Exp Immunol; 1992 Aug; 89(2):170-3. PubMed ID: 1379130
    [No Abstract]   [Full Text] [Related]  

  • 8. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
    Murase N; Demetris AJ; Tanabe M; Miyazawa H; Valdivia LA; Nakamura K; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):425-6. PubMed ID: 7679817
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
    Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive agents--advances of the developmental studies and the mode of action].
    Ochiai T; Isono K; Gunji Y; Nagata M
    Nihon Rinsho; 1991 Jun; 49(6):1436-41. PubMed ID: 1715926
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
    Zeevi A; Yao GZ; Venkataramanan R; Duquesnoy RJ; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):781-3. PubMed ID: 7679843
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of immunosuppression by lymphocyte functions in human blood.
    Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF
    Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of immunosuppressants on human leukocyte NADPH oxidase.
    Engelbrecht ME; Oosthuizen MM; Myburgh JA
    Ann N Y Acad Sci; 1994 Jun; 723():436-8. PubMed ID: 7518204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.